Stopped early
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
NCT00544076 · City of Hope Medical Center · Updated 2 Jan 2019
- What is being tested
- sildenafil citrate; alprostadil; robotic-assisted laparoscopic surgery; quality-of-life assessment; questionnaire administration
- For
- Prostate Cancer; Male Erectile Disorder; Stage I Prostate Cancer; Stage II Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years to 65 years. About 110 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Jan 2006, ends April 2012. Registered 16 Oct 2007.
- Results
- Posted on the registry on 2 Jan 2019.
In the researchers' words
RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing robotic-assisted radical prostatectomy for nonmetastatic prostate cancer.
Sites
- City of HopeDuarte, California, United States